CompletedNCT01527500
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
PHASE2 · 158 planned enrolment
- Countries listed
- 1
- Registry update
- January 5, 2021
immortal.lifeTrial registrations containing the exact intervention label LFG316.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 158 planned enrolment
PHASE2 · 1 planned enrolment
PHASE1 · 24 planned enrolment